Edesa Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Edesa Biotech and other ETFs, options, and stocks.About EDSA
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo.
CEOPardeep Nijhawan
CEOPardeep Nijhawan
Employees16
Employees16
HeadquartersMarkham, Ontario
HeadquartersMarkham, Ontario
Founded2007
Founded2007
Employees16
Employees16
EDSA Key Statistics
Market cap14.40M
Market cap14.40M
Price-Earnings ratio-1.28
Price-Earnings ratio-1.28
Dividend yield—
Dividend yield—
Average volume14.19K
Average volume14.19K
High today$2.10
High today$2.10
Low today$2.04
Low today$2.04
Open price$2.09
Open price$2.09
Volume25.97K
Volume25.97K
52 Week high$5.59
52 Week high$5.59
52 Week low$1.55
52 Week low$1.55
People also own
Based on the portfolios of people who own EDSA. This list is generated using Robinhood data, and it’s not a recommendation.